Ftse Mib
38.979,69
0,84%
DAX
23.154,57
0,94%
S&P 500
5.675,12
0,64%
NASDAQ
17.808,66
0,31%
Bitcoin
83.932,58
1,67%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Germania TG Teva Pharmaceutical Industries Ltd (TEV) Teva Pharmaceutical Industries Ltd (TEV) Notizie

Teva Pharmaceutical Industries Ltd

TEV
15,30
0,25 (1,66%)
17 Mar 2025 - Chiuso
Dati in Tempo Reale
Borsa: Tradegate
Tipo: Azione Ordinaria
Valuta: EUR

Ultime notizie

Data Ora Fonte Titolo
03/3/202522:30UKREGTeva to Present at Barclays Global Healthcare Conference and..
27/2/202514:00UKREG2025 Community Routes: Access to Mental Health Care Grants..
25/2/202522:00UKREGTeva and Medincell Announce FDA Acceptance of Supplemental..
22/2/202508:20UKREGTeva and Sanofi Present New Positive Phase 2b Study Results..
21/2/202513:54UKREGLes besoins du patient au centre de toutes les priorités :..
21/2/202513:54UKREGDer Patient steht an erster Stelle: Warum Europa handeln..
21/2/202512:00UKREGTeva and Alvotech Announce SELARSDI™ (ustekinumab-aekn)..
18/2/202522:30UKREGTeva to Host Conference Call on February 24, 2025 to Discuss..
18/2/202512:00UKREGAlvotech and Teva Announce Filing Acceptance of U.S...
29/1/202513:00UKREGTeva Delivers Second Consecutive Year of Growth; Announces..
27/1/202512:00UKREGAlvotech and Teva Announce Filing Acceptance of U.S...
14/1/202504:25UKREGTeva gibt Zusammenarbeit zur Vermarktung des Formycon..
14/1/202504:25UKREGTeva annonce un partenariat en vue de commercialiser le..
13/1/202507:00UKREGTeva Announces Collaboration to Commercialize Formycon’s..
10/1/202514:30UKREGSamsung Bioepis and Teva Enter into a Strategic Partnership..
23/12/202422:30UKREGTeva to Present at the 43rd Annual J.P. Morgan Healthcare..
20/12/202422:30UKREGTeva to Host Conference Call to Discuss Fourth Quarter and..
17/12/202413:30UKREGTeva and Sanofi Announce Duvakitug (Anti-TL1A) Positive..
11/12/202414:00UKREGTeva Announces New Patient Access Program with Direct Relief..
06/12/202400:00UKREGTeva Announces Agreement to Divest Teva-Takeda, its Business..
04/12/202414:10UKREGTeva präsentiert positive Wirksamkeits- und Sicherheitsdaten..
04/12/202414:10UKREGTeva présente des données positives sur l’efficacité et la..
04/12/202408:00UKREGTeva Presents Positive Efficacy and Safety Data of AJOVY®..
26/11/202400:00UKREGTeva to Present at the 7th Annual Evercore ISI HealthCONx..
08/11/202422:30UKREGTeva to Present at the Jefferies London Healthcare..
06/11/202413:00UKREGTeva Announces Strong Financial Results for the Third..
01/11/202420:05UKREGTeva Presents New Tardive Dyskinesia Data at Psych Congress..
01/11/202420:00UKREGTeva Presents Latest Schizophrenia Treatment Research,..
31/10/202412:29UKREGTeva Statement on European Commission Decision; Company to..
22/10/202413:00UKREGAlvotech and Teva Announce U.S. FDA Approval of Additional..
08/10/202413:00UKREGTeva Prolia® (Denosumab) Biosimilar Candidate is Accepted..
03/10/202414:30UKREGTeva and mAbxience Expand Strategic Partnership to include..
01/10/202414:29UKREGTeva Announces Launch of the First and Only Generic Version..
30/9/202422:30UKREGTeva to Host Conference Call to Discuss Third Quarter 2024..
23/9/202407:00UKREGTeva Announces Long Term Efficacy and Safety of..
21/9/202410:15UKREGTeva Presents New Phase 3 Efficacy, Safety and Tolerability..
21/9/202410:10UKREGNew Data Provide Treatment Insights into Options for..
11/9/202422:30UKREGTeva to Present at the Bank of America 2024 Global..
26/8/202423:00UKREGTeva to Present at the Morgan Stanley 22nd Annual Global..
31/7/202413:00UKREGTeva Announces Strong Growth in Second Quarter Revenues..
Apertura: 14,85 Min: 14,70 Max: 15,30
Chiusura: 15,05

La tua Cronologia

TG
TEV
Teva Pharmaceutical Indu...
TG
K40
Kandi Technologies
TG
6V3
Lufax
BOV
BIJR39
S&P Small Cap ETF BDR
TG
7M1
Mips AB
TG
HNM
Ormat Technologies
TG
AF8
AF Gruppen ASA
TG
12F
Fortis
TG
BVF
Bausch Health Companies
TG
4XN
Xunlei
TG
NL0
GRAIL
TG
3Y0
Triple Flag Precious Met...
TG
G6G
GrafTech
TG
HQS
Highwoods Properties
TG
NNL
Monex
TG
RYD
Ryder System
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci